Constitutive AMPK activation prevents hepatocellular carcinoma development through inhibition of HNF4α activity
Science Advances · 10.04.2026 · 12 (15)
DOI: 10.1126/sciadv.aea8017 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 10.04.2026. Verfasst von Zhen Sun und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA. Hauptthemen laut MEDLINE: Hepatocyte Nuclear Factor 4, AMP-Activated Protein Kinases, Carcinoma, Hepatocellular, Liver Neoplasms. Die Arbeit nennt 132 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIGMS NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Hepatocellular carcinoma (HCC) is a major cause of cancer-related mortality and is largely driven by metabolic disorders such as obesity and type 2 diabetes. The AMP-activated protein kinase (AMPK) is a master regulator of metabolism, and its activation has been proposed as a therapeutic strategy for treating metabolic disorders. However, although AMPK activity is down-regulated in HCC, the precise role of AMPK in HCC development has not been clearly delineated. Here, we investigated the ability of constitutive AMPK activation to prevent HCC development using a constitutively active AMPK transgenic mouse model and a pharmacological AMPK activator. We observed that AMPK activation substantially reduced tumor formation in both diethylnitrosamine (DEN)–induced and streptozocin-induced (STAM) models of HCC via altered bile acid metabolism and inhibition of hepatic nuclear factor alpha (HNF4α) signaling. These findings provide mechanistic insights into AMPK biology and highlight the potential of AMPK as a therapeutic target, emphasizing the intricate interplay between metabolic dysregulation and cancer development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA.
- Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA.
- Advanced Technology Core, Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA.
ORCID-Profile: Zhen Sun, Bernard Linares, Nagireddy Putluri, Jeanine L Van Nostrand
Förderung
- NCI NIH HHS
- NIGMS NIH HHS
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases
- Cancer Prevention and Research Institute of Texas
- Dan L. Duncan Cancer Center, Baylor College of Medicine
Zitieren
APA
Sun, Z., Linares, B., Urdiales, C., Alsarmi, F., Sang, B., Putluri, N., & Van Nostrand, J. L. (2026). Constitutive AMPK activation prevents hepatocellular carcinoma development through inhibition of HNF4α activity. Science Advances, 12(15). https://doi.org/10.1126/sciadv.aea8017
Vancouver
Sun Z, Linares B, Urdiales C, Alsarmi F, Sang B, Putluri N, et al. Constitutive AMPK activation prevents hepatocellular carcinoma development through inhibition of HNF4α activity. Science Advances. 2026;12(15). doi:10.1126/sciadv.aea8017
BibTeX
@article{Sun2026,
author = {Sun, Zhen and Linares, Bernard and Urdiales, Cassidy and Alsarmi, Fiyad and Sang, Boyuan and Putluri, Nagireddy and Van Nostrand, Jeanine L},
title = {Constitutive AMPK activation prevents hepatocellular carcinoma development through inhibition of HNF4α activity},
journal = {Science Advances},
year = {2026},
volume = {12},
number = {15},
doi = {10.1126/sciadv.aea8017}
}
EUVIMED